{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:02:39Z","timestamp":1792641759232,"version":"4.5.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Arrhythmia and Electrophysiology"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>\n              CaM (calmodulin)-mediated long-QT syndrome is a genetic arrhythmia disorder (calmodulinopathies) characterized by a high prevalence of life-threatening ventricular arrhythmias occurring early in life. Three distinct genes (\n              <jats:italic toggle=\"yes\">CALM1<\/jats:italic>\n              ,\n              <jats:italic toggle=\"yes\">CALM2<\/jats:italic>\n              , and\n              <jats:italic toggle=\"yes\">CALM3<\/jats:italic>\n              ) encode for the identical CaM protein. Conventional pharmacotherapies fail to adequately protect against potentially lethal cardiac events in patients with calmodulinopathy.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>\n              Five custom-designed\n              <jats:italic toggle=\"yes\">CALM1<\/jats:italic>\n              -,\n              <jats:italic toggle=\"yes\">CALM2<\/jats:italic>\n              -, and\n              <jats:italic toggle=\"yes\">CALM3<\/jats:italic>\n              -targeting short hairpin RNAs (shRNAs) were tested for knockdown (KD) efficiency using TSA201 cells and reverse transcription-quantitative polymerase chain reaction. A dual-component suppression and replacement (SupRep)\n              <jats:italic toggle=\"yes\">CALM<\/jats:italic>\n              gene therapy (CALM-SupRep) was created by cloning into a single construct\n              <jats:italic toggle=\"yes\">CALM1<\/jats:italic>\n              -,\n              <jats:italic toggle=\"yes\">CALM2<\/jats:italic>\n              -, and\n              <jats:italic toggle=\"yes\">CALM3-specific shRNAs that produce<\/jats:italic>\n              KD (suppression) of each respective gene and a shRNA-immune\n              <jats:italic toggle=\"yes\">CALM1<\/jats:italic>\n              cDNA (replacement). CALM1-F142L, CALM2-D130G, and CALM3-D130G induced pluripotent stem cell-derived CMs were generated from patients with CaM-mediated long-QT syndrome. A voltage-sensing dye was used to measure action potential duration at 90% repolarization (APD90).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>\n              Following shRNA KD efficiency testing, a candidate shRNA was identified for\n              <jats:italic toggle=\"yes\">CALM1<\/jats:italic>\n              (86% KD),\n              <jats:italic toggle=\"yes\">CALM2<\/jats:italic>\n              (71% KD), and\n              <jats:italic toggle=\"yes\">CALM3<\/jats:italic>\n              (94% KD). The APD90 was significantly prolonged in CALM2-D130G (647\u00b19 ms) compared with CALM2-WT (359\u00b112 ms;\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              &lt;0.0001). Transfection with\n              <jats:italic toggle=\"yes\">CALM<\/jats:italic>\n              -SupRep shortened the average APD90 of CALM2-D130G to 457\u00b119 ms (66% attenuation;\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              &lt;0.0001). Additionally, transfection with\n              <jats:italic toggle=\"yes\">CALM<\/jats:italic>\n              -SupRep shortened the APD90 of CALM1-F142L (665\u00b19 to 410\u00b115 ms;\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              &lt;0.0001) and CALM3-D130G (978\u00b181 to 446\u00b16 ms;\n              <jats:italic toggle=\"yes\">P<\/jats:italic>\n              &lt;0.001).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>\n              We provide the first proof-of-principle suppression-replacement gene therapy for CaM-mediated long-QT syndrome. The CALM-SupRep gene therapy shortened the pathologically prolonged APD90 in\n              <jats:italic toggle=\"yes\">CALM1<\/jats:italic>\n              -,\n              <jats:italic toggle=\"yes\">CALM2<\/jats:italic>\n              -, and\n              <jats:italic toggle=\"yes\">CALM3-variant<\/jats:italic>\n              CaM-mediated long-QT syndrome induced pluripotent stem cell-derived CM lines. The single CALM-SupRep construct may be able to treat all calmodulinopathies, regardless of which of the 3 CaM-encoding genes are affected.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circep.123.012036","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:01:45Z","timestamp":1722243705000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Single Construct Suppression and Replacement Gene Therapy for the Treatment of All\n            <i>CALM1<\/i>\n            -,\n            <i>CALM2<\/i>\n            -, and\n            <i>CALM3<\/i>\n            -Mediated Arrhythmia Disorders"],"prefix":"10.1161","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-2906","authenticated-orcid":true,"given":"Samantha K.","family":"Hamrick","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (S.K.H., C.S.J.K., D.J.T., M. Gencarelli, K.E.T., M. Gluscevic, M.J.A.), Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S. John","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (S.K.H., C.S.J.K., D.J.T., M. Gencarelli, K.E.T., M. Gluscevic, M.J.A.), Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4554-2244","authenticated-orcid":true,"given":"David J.","family":"Tester","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (S.K.H., C.S.J.K., D.J.T., M. Gencarelli, K.E.T., M. Gluscevic, M.J.A.), Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4325-963X","authenticated-orcid":true,"given":"Manuela","family":"Gencarelli","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (S.K.H., C.S.J.K., D.J.T., M. Gencarelli, K.E.T., M. Gluscevic, M.J.A.), Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2540-8243","authenticated-orcid":true,"given":"Kathryn E.","family":"Tobert","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (S.K.H., C.S.J.K., D.J.T., M. Gencarelli, K.E.T., M. Gluscevic, M.J.A.), Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gluscevic","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (S.K.H., C.S.J.K., D.J.T., M. Gencarelli, K.E.T., M. Gluscevic, M.J.A.), Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory) (S.K.H., C.S.J.K., D.J.T., M. Gencarelli, K.E.T., M. Gluscevic, M.J.A.), Mayo Clinic, Rochester, MN."},{"name":"Department of Cardiovascular Medicine (Division of Heart Rhythm Services, Windland Smith Rice Genetic Heart Rhythm Clinic) (M.J.A.), Mayo Clinic, Rochester, MN."},{"name":"Department of Pediatric and Adolescent Medicine (Division of Pediatric Cardiology) (M.J.A.), Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.115.001323"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001216"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz311"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1993.1211"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00176"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.202012667"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.091"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.115.001370"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309283"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051836"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.122.003719"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.002950"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135952"}],"container-title":["Circulation: Arrhythmia and Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCEP.123.012036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T21:07:41Z","timestamp":1748552861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCEP.123.012036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1161\/CIRCEP.123.012036"],"URL":"https:\/\/doi.org\/10.1161\/circep.123.012036","relation":{},"ISSN":["1941-3149","1941-3084"],"issn-type":[{"value":"1941-3149","type":"print"},{"value":"1941-3084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2023-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}